Blog

October 11, 2019October 15, 2019

Lanctôt Optical Gets Distribution of BA&SH Eyewear in Canada

Lanctôt Optical has become the exclusive distributor of the French brand BA&SH Eyewear in Canada. Several optical stores served by Lanctôt are already offering this new brand to their clients.

“We developed a real affection for that brand for its dynamism and youthfulness, values that are great assets to successfully promote a brand anywhere in the world,” says Stephane Leroy, vice-president of Lanctôt Optical.

Ready-to-wear fashion brand BA&SH has been launched in 2003 by Barbara Baccara and Sharon Krief, two friends who dreamed of creating the ideal wardrobe. Their simple yet unique collections have since frequently appeared in different media and have garnered acclaims from influencers and the public.

Developed in collaboration with Seaport, their eyewear line has three collections. The Feeling Good styles are entirely composed of metal, whereas the Duos combine acetate and metal, and the Authentiques are completely made of acetate. Both optical and sun styles can be found in all three collections.

Click HERE for the full press release.

October 11, 2019October 9, 2019

From Supercars to Glasses: McLaren Automotive Launches Eyewear Collection

Prisme Optical Group announces that they have signed an exclusive distribution agreement for the McLaren eyewear collection in Canada.

The British-based supercar maker has lifted the curtain on its inaugural range of sunglasses and ophthalmic frames. Made in collaboration with optical specialist L’Amy Group, the McLaren Vision Collection is made up of a wide mix of designs imbued with the McLaren DNA.

The collection is made up of Core, Premium and Bespoke frames. The latter set utilizes Industry-first 3D-printed titanium frames and option of face-scanning technology for the perfect tailored fit.

The collection is also the first to use Leica’s Eyecare latest lenses which feature AquaDura Vision anti-reflective, hydrophobic and oleophobic coatings as well as special tints for specific environments and uses: driving, skiing, sailing, city life, and playing golf.

The Premium collection was awarded the SILMO d’Or Design Award for Technology and Innovation when it was previewed in 2018 at the SILMO optical trade show in Paris.

Click HERE for the full press release.

October 10, 2019October 9, 2019

WCO Recognizes World Sight Day on October 10, 2019

The World Council of Optometry (WCO), along with the International Agency for the Prevention of Blindness, recognizes Thursday, October 10 as World Sight Day. The theme for 2019 is Vision First!

The WCO represents over 200,000 optometrists in more than 80 countries, with nearly 300 combined Country, Affiliate, Corporate, and Individual Memberships across six world regions – Africa, Asia Pacific, Eastern Mediterranean, Europe, Latin America and North America.

Their mission is to facilitate the enhancement and development of eye and vision care worldwide, through advocacy, education, policy development and humanitarian outreach.

Dr. Scott Mundle, President of WCO, encourages everyone to be vigilant in our collective goal of eliminating avoidable blindness. “With the impending crisis of significant levels of high myopia on the horizon, WCO is taking an active role in the management and prevention of myopia and other eye diseases,” said Dr. Mundle. WCO has been working with other organizations, including the IAPB, to further this cause. With the release of the World Health Organization of the World Report on Vision, it is our hope that myopia management, uncorrected refractive error and eye diseases, including cataract, glaucoma and age-related macular degeneration, will have the global attention they deserve.

Included in the World Report on Vision Report is the recommendation that member WHO nations adopt a Universal Health Coverage strategy to deal with these eye health issues. “We urge governments around the world to act upon this call to action by the World Health Organization,” says Dr. Mundle.

Click HERE for the full press release.

October 9, 2019October 9, 2019

Eye Tracking Results Could Predict Alzheimer’s

People with Alzheimer’s Disease (AD) gradually lose the ability to control attention and develop impairments of a gaze-shift towards a prominent stimulus, as well away from this stimulus.

A noteworthy question is whether eye-movement impairments are detectable in people who are in a preclinical stage of AD and therefore at a greater risk of developing clinical dementia.

AD often progresses from mild cognitive impairment (MCI), which involves a slight decline in memory and reasoning that is not serious enough to interfere with daily activities.

According to some studies, 46% of people who are diagnosed with MCI develop dementia within 3 years.

There are two forms of MCI that show different symptoms, amnesic (aMCI) and nonamnesic (naMCI). The former primarily affects memory, whereas the latter affects other cognitive skills. Having the aMCI form increases the risk of Alzheimer’s significantly more than naMCI.

Researcher Thom Wilcockson, from the school of sports, Exercise, and Health Sciences at Loughborough University in the UK, and his colleagues, carried out the first study of its kind using eye tracking tests to see if they could distinguish participants of the two forms based on their results.

The research involved 42 participants with aMCI, 47 people with naMCI, 68 participants who were diagnosed with Alzheimer’s disease, and 92 age-matched controls who were cognitively healthy. Participants were given computer-based tasks and asked to avoid looking at a distracting stimulus, such as a dot that appears at random places on the screen.

The results revealed that based on the participants’ eye tracking results, it was possible to distinguish between the participants who had aMCI and those who had naMCI. Furthermore, the eye tracking results of those with aMCI closely resembled the scores of those with Alzheimer’s disease.

The study’s lead author stated that “the results indicate that it is possible to predict which MCI patients are more likely to develop Alzheimer’s disease.” If we can detect Alzheimer’s early on, there’s a better chance of early treatment, improvement of a person’s brain health and reduction in symptoms.

“I hope to build on this research and continue the development of eye tracking mythologies for early diagnosis.” Concluded the lead researcher.

https://www.medicalnewstoday.com/articles/326161.php

https://www.aging-us.com/article/102118/text

October 9, 2019September 17, 2019

X-Ide: Designed to Amaze and Never Cliched

The new X-Ide collection embodies contemporary flair and timeless elegance. The “Jazz” emphasizes the eyes, a shape and thin metal frame with a brow piece embellished with a unique diamond effect detail makes it an eyewear classic informed by a fresh, modern flair. Entirely made in Italy, Fine craftsmanship and painstaking handiwork are showcased in this artisan frames.

Distributed by Mood Eyewear: http://www.moodeyewear.com/